Select publications: Chemotherapy in the treatment of HER2-positive metastatic disease

Baselga J. Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: Pivotal trials. Oncology 2001;61(Suppl 2):14-21. Abstract

Burris HA 3rd. Docetaxel (Taxotere) plus trastuzumab (Herceptin) in breast cancer. Semin Oncol 2001;28(1 Suppl 3):38-44. Abstract

Burstein HJ et al. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol 2001;19(10):2722-30. Abstract

Christodoulou C et al. Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer. Anticancer Res 2003;23(1B):737-44. Abstract

Eiermann W; International Herceptin Study Group. Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data. Ann Oncol 2001;12(Suppl 1)57-62. Abstract

Leyland-Jones B. Trastuzumab: Hopes and realities. Lancet Oncol 2002;3(3):137-44. Abstract

Ligibel JA, Winer EP. Trastuzumab/chemotherapy combinations in metastatic breast cancer. Semin Oncol 2002;29(3 Suppl 11):38-43. Abstract

Miller KD et al. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer. Oncology (Huntingt) 2001;15(2 Suppl 3):38-40. Abstract

Montemurro F et al. Safety and activity of docetaxel and trastuzumab in HER2-overexpressing metastatic breast cancer: A pilot Phase II study. Am J Clin Oncol 2003;26(1):95-7. Abstract

O'Shaughnessy J. Gemcitabine and trastuzumab in metastatic breast cancer. Semin Oncol 2003;30(2 Suppl 3):22-6. Abstract

Pegram MD, O'Callaghan C. Combining the anti-HER2 antibody trastuzumab with taxanes in breast cancer: Results and trial considerations. Clin Breast Cancer 2001;2(Suppl 1)15-9. Abstract

Seidman AD et al. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol 2001;19(10):2587-95. Abstract

Sledge GW Jr. Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer. Semin Oncol 2003;30(2 Suppl 3):19-21. Abstract

Winer EP, Burstein HJ. New combinations with Herceptin in metastatic breast cancer. Oncology 2001;61(Suppl 2)50-7. Abstract